(Q28266738)

1

0 references

Nancy Breen

3

0 references

Robert J Uhler

4

0 references

Arnold L Potosky

5

0 references

Donald Blackman

Screening for prostate cancer: recommendation and rationale

6

0 references

language of work or name

English

0 references

publication date

June 2004

0 references

published in

Preventive Medicine

0 references

volume

38

0 references

issue

6

0 references

page(s)

732-44

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Impact of screening on incidence and mortality of prostate cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate cancer screening practices and beliefs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Knowledge, attitudes, and screening practices among older men regarding prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Mammography utilization, public health impact, and cost-effectiveness in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Factors associated with the use of screening mammography in a primary care setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Predictive margins with survey data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Colorectal cancer screening: clinical guidelines and rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

The validity of male patients' self-reports regarding prostate cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

The accuracy of primary care patients' self-reports of prostate-specific antigen testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Concordance of self-reported data and medical record audit for six cancer screening procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Gender differences in psychosocial adjustment to chronic pain and expenditures for health care services used

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Should we screen for prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Prostate cancer screening--a physician survey in Missouri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Attitudes and practices of primary care physicians for prostate cancer screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Uncertainty in prostate cancer care: the physician's role in clearing the confusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005

Impact of undergoing prostate carcinoma screening on prostate carcinoma-related knowledge and distress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2004.01.005